Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cephalalgia : an International Journal of Headache|November 26, 2024
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional studyGiorgio Dalla Volta, Antonio Russo, Marcello Silvestro, et al.
Therapeutic Advances in Neurological Disorders|December 25, 2025
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study)Gloria Vaghi, Luigi Francesco Iannone, Michele Corrado, et al.
Frontiers in Neurology|September 22, 2025
Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional studyMarina Romozzi, Luigi Francesco Iannone, Marcello Silvestro, et al.
CNS Drugs|November 24, 2023
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort StudyValeria Caponnetto, Antonio Russo, Marcello Silvestro, et al.
Sleep Medicine|April 29, 2026
Sleep disorders in children with Cri du Chat syndrome: A questionnaire-based studyAlessandro Ferretti, Giulia Bellone, Anteo Di Napoli, et al.
Cephalalgia : an International Journal of Headache|June 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study)Claudia Altamura, Luigi Francesco Iannone, Flavia Lo Castro, et al.
Cephalalgia : an International Journal of Headache|March 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerabilityLuigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis, et al.
Cephalalgia : an International Journal of Headache|February 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study)Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano, et al.
Cephalalgia : an International Journal of Headache|April 25, 2025
Evidence-based guidelines for the pharmacological treatment of migraine, summary versionRaffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Cephalalgia : an International Journal of Headache|April 25, 2025
Evidence-based guidelines for the pharmacological treatment of migraineRaffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Pageof 5